XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (ticker: XYN) is a clinical-stage biopharmaceutical company focused on oncology therapeutics that established a public reporting presence in the U.S. markets in 2018. The company filed a Form 10-Q with the Securities and Exchange Commission on May 14, 2018, under accession number 0001213900-18-006093, marking a quarterly disclosure of its financial position and operations within the healthcare and life-sciences sector. Xynomic pursued a strategy centered on in-licensing and advancing cancer drug candidates. Sponsor information and full deal-structure details are available in the SpacDesk database. Sign up at SpacDesk for complete filing history, sponsor records, and real-time SPAC analytics on XYN and thousands of other vehicles.